Inhibition of Pneumocystis dihydrofolate reductase by analogs of pyrimethamine, methotrexate and trimetrexate.
Dihydrofolate reductase was obtained from Pneumocystis carinii isolated from heavily infected lungs of female Sprague-Dawley rats infected by transtracheal inoculation. The enzyme differed significantly from other forms of dihydrofolate reductase in response to KCl and to antifolate drugs. Dihydrofolate reductase from P. carinii was used to assess activity of analogs of pyrimethamine, methotrexate, and trimetrexate. One pyrimethamine analog was selective for P. carinii dihydrofolate reductase; potency was in the micromolar range. In contrast, 21 methotrexate analogs and 2 trimetrexate analogs were selective for P. carinii dihydrofolate reductase; potencies for these were in the nanomolar range.
Queener
S F
SF
Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis 46202-5120.
D000818:Animals; D005260:Female; D005493:Folic Acid Antagonists; D008727:Methotrexate / Q000031:analogs & derivatives / Q000494:pharmacology*; D015394:Molecular Structure; D011010:Pneumocystis / Q000187:drug effects / Q000201:enzymology*; D011739:Pyrimethamine / Q000031:analogs & derivatives / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D012440:Saccharomyces / Q000187:drug effects / Q000201:enzymology; D016597:Trimetrexate / Q000031:analogs & derivatives / Q000494:pharmacology*
D005493:Folic Acid Antagonists; D016597:Trimetrexate; D008727:Methotrexate; D011739:Pyrimethamine